ClinicalTrials.gg
Enrolling by invitationNCT05740462Updated Jul 26, 2024

Hydroponic Fortification and Dietary App Effect on Nutrients Level (Harvest)

An interventional study of Recipes consumption and Hydroponic unit in Iron Deficiency (Without Anemia) and B12 Deficiency Vitamin, sponsored by Quadram Institute Bioscience. Enrolling by invitation at 1 site in United Kingdom. Open to female participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-26.

Sponsored by Quadram Institute Bioscience · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 5 months ago, but the record still lists the study as enrolling by invitation.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Iron Deficiencies with a site in United Kingdom — 2 open to participants now, 2 under way, none of them phase 3. Iron Deficiencies · United Kingdom.

Planned enrollment
9th of 19
52 · median 50
Started
2023
with 1 other
No phase
11 of 22
1 open now
Registered
20th of 22
by date
Lead sponsor
3 of 22
Quadram Institute Bioscience

Among the 22 studies in Iron Deficiencies with a site in United Kingdom, this one is the 9th largest by planned enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2023, is one of 11 with no phase, and was the 20th registered.

Iron Deficiencies

386 studies on the registry are indexed under Iron Deficiencies; 78 are open to participants now.

Browse Iron Deficiencies studies →

Open to participants now

2 of the 22 studies in Iron Deficiencies with a site in United Kingdom are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 53 Iron Deficiencies studies recruiting now, 23 (43%) set no upper age limit and 26 (49%) stop at 75 or younger; 14 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 60 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Iron Deficiencies with a site in United Kingdom, or all of them as a file.
02

Study summary

Veganism and vegetarianism have clear benefits where they have a lower risk of many health issues. However, they also have a higher risk of nutrients and vitamin deficiency such as iron and vitamin B12. Iron can be found in plant-based food but in varying quantities, whereas vitamin B12 is mainly found in red meat, thus vegans and vegetarians can only take this vitamin in supplements such as tablets. In this study, the investigators are testing two interventions, the consumption of recipes with a certain iron amount to increase iron levels, and the consumption of vitamin B12 biofortified plants to increase serum B12 levels in vegan and vegetarian participants.

Read the detailed description

Iron is present in plant and animal-derived foods but the fractional absorption of iron from plant foods (that is the percent of iron absorbed from a consumed quantity) is often low (approx 10%) compared to iron from animal sources 25%-30%. It is therefore more challenging for vegans and vegetarians to achieve the Reference Nutrient Intake (RNI) for iron (8.7 mg/day for men over 18 and women over 50, 14.8 mg/day for women aged 18-50), and they are likely to absorb less of that iron and therefore are more likely to become iron depleted.

Plants do not synthesise vitamin B12 and unless fortified, plant-derived foods and beverages do not contain any vitamin B12. the RNI for vitamin B12 in the UK is 1.5 µg/day, therefore it is crucial that vegans and vegetarians take B12 supplements if they don't consume B12-fortified foods or find other ways of incorporating this vitamin into their diets.

The HARVEST study is a 17-week randomised, controlled, double-blinded, parallel dietary intervention study conducted at the Quadram Institute Clinical Research Facility (QI CRF), Norwich, UK. Investigators are seeking vegan or vegetarian women (18 to 50 years old) to test two interventions, iron-specific recipes and B12 biofortified plants grown in a kitchen garden. There are a total of 4 visits (1 screening visit, 2 2-hours visits and 1 short visit). Investigators will assess blood samples for serum ferritin, serum B12 and other iron and B12 biomarkers. Investigators will ask the participant to complete lifestyle questionnaires regarding their dietary pattern, fatigue level and satisfaction and impression of the study tools.

03

Conditions studied

  • Iron Deficiency (Without Anemia)
  • B12 Deficiency Vitamin

Keywords

  • Hydroponic
  • Dietary app
  • Salad greens
  • Iron ferritin
  • Vitamin B12
  • vegan recipes
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Women over 18 years with a regular menstruation cycle (>21 and \<40 days).
  2. Has followed a vegan or vegetarian diet that does not include the consumption of meat or fish for at least 1 year.
  3. Willing to remain on their background diet for the duration of the study.
  4. Those who are on a routine regimen of iron and/or vitamin B12 supplements must maintain the same doses 3 month prior to the study and during the duration of the study.
  5. Non-anaemic, (Hb) concentration ≥120 g/L.
  6. SF >15 µg/L and \<60 µg/L [WHO uses the following cut-offs for context: below 15 µg/L indicates iron deficiency, 16-40 µg/L indicates borderline deficiency, and 41 - 150 µg/L is normal].
  7. (BMI) between 18.5 - 40 kg/m2.
  8. Live within 40 miles of the Norwich Research Park.
  9. Willing to consume plants grown in the hydroponic unit (e.g., spinach, rocket, mizuna) if they agreed to have a unit.
  10. Access to a smartphone or online platform a well as access to the internet.

Exclusion criteria

Exclusion Criteria:

  1. Those who have known allergies to the hydroponically grown salad greens (spinach, rocket, mizuna).
  2. Flexitarian (consumes meat intermittently) vegetarian.
  3. Those with menstruation cycle time periods of \<21 or >40-days
  4. at screening visit \< 18.5 kg/m2 (underweight) and > 40 kg/m2 (severely obese).
  5. Those diagnosed with or undergoing treatment for anaemia.
  6. Currently pregnant, lactating or trying to conceive.
  7. High alcohol consumption, consuming more than 2 drinks per day, can elevate the risk for iron overload.
  8. Current smoker or has only ceased in the last 6 months.
  9. Diagnosed medical conditions that may impact the study outcomes will be considered on an individual basis.
  10. Those with an eating disorders, which may impact the study outcome.
  11. On, or about to start, a diet programme such as the 5:2 programme (5:2 programme is where an individual would eat normally for five days a week, and fast for two days a week by reducing calorie consumption).
  12. Unable to give written or verbal .
  13. Individuals who cannot understand the written instructions/questionnaires.
  14. Unwilling to give GP contact details.
  15. Participating in another dietary intervention study or has given blood in another research study during the last 3 months.
  16. Any person related to or living with any member of the study team.
  17. Those who are part of the Line Manager/supervisory structure of the Chief Investigator.
  18. Those who have been asked to self-isolate or have been diagnosed with COVID-19 in the last 14 days. However, participants can be rescreened 7 days after the isolation period.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Dietary app 1

    Dietary app recommends high iron or iron-focused recipes

    Behavioral: Recipes consumption · Behavioral: Hydroponic unit

  • Sham comparator
    Dietary app 2

    Dietary app recommends standard iron recipes

    Behavioral: Recipes consumption · Behavioral: Hydroponic unit

  • Experimental
    Hydroponic unit 1

    Growing vitamin B12 biofortified plants in a hydroponic unit and will be randomised to dietary app 1 or 2

    Behavioral: Recipes consumption · Behavioral: Hydroponic unit

  • No intervention
    Hydroponic unit 2

    No hydroponic unit be given to participants and will be randomised to dietary app 1 or 2

Interventions

  • BehavioralRecipes consumption

    Participants will eat two recipes a day for 17 weeks

  • BehavioralHydroponic unit

    Participants will grow vitamin B12 biofortified plants for 17 weeks and consume (10 grams) of plant material for 11 weeks.

06

What researchers measure

Primary outcomes

  1. Change in serum ferritin after the dietary app intervention

    Comparison of serum ferritin at baseline and after the intervention

    Time frame: Week: 0, 6/7 and 17

  2. Change of serum B12 after the hydroponic unit intervention

    Comparison of serum B12 at baseline and after the intervention

    Time frame: Week: 6/7 and 17

Secondary outcomes

  1. Change in high sensitivity C-reactive protein (hsCRP) with dietary app (high or standard iron) recipe intervention

    comparison of hsCRP at baseline and after dietary app intervention

    Time frame: Week: 0 to 6/7, 6/7 to 17, and 0 to 17

  2. Change in full blood count (FBC) with dietary app (high or standard iron) recipe intervention

    comparison of FBC in venous blood sample at baseline and after dietary app intervention

    Time frame: Week: 0 to 6/7, 6/7 to 17, and 0 to 17

  3. Change in soluble transferrin receptor (sTfR) with dietary app (high or standard iron) recipe intervention

    comparison of sTfR in venous blood sample at baseline and after dietary app intervention

    Time frame: Week: 0 to 6/7, 6/7 to 17, and 0 to 17

  4. Change in alpha 1 acid glycoprotein (AGP) with dietary app (high or standard iron) recipe intervention

    comparison of AGP in venous blood sample at baseline and after dietary app intervention

    Time frame: Week: 0 and 17

  5. Change in holo-transcobalamin (Holo-TC) after the hydroponic unit (biofortification) intervention

    Measurement of holo-TC in venous blood sample at baseline and after the hydroponic unit intervention

    Time frame: Week: 0 and 17

  6. Change in methylmalonic acid (MMA) after the hydroponic unit (biofortification) intervention

    Measurement of MMA in venous blood sample at baseline and after the hydroponic unit intervention

    Time frame: Week: 0 and 17

  7. Change in total plasma homocysteine (tHcy) after the hydroponic unit (biofortification) intervention

    Measurement of tHcy in venous blood sample at baseline and after the hydroponic unit intervention

    Time frame: Week: 0 and 17

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Jun 2025, 24 months after the start.

Of 77 non-industry interventional studies with no phase under Iron Deficiencies, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 24 months is above that.

Counting every sponsor, half of 89 studies reached it within 10 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2023
First posted
Feb 23, 2023
StartActual
May 4, 2023
Primary completionEst.
Jun 1, 2025
CompletionEst.
Sep 1, 2025
Last update
Jul 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05740462
Lead sponsor
Quadram Institute Bioscience
Collaborators
Norfolk and Norwich University Hospitals NHS Foundation Trust
Responsible party
Sponsor
First posted
Feb 23, 2023
Start date
May 4, 2023
Primary completion
Jun 1, 2025 (estimated)
Completion
Sep 1, 2025 (estimated)
Last update
Jul 26, 2024

Study contacts

Paul A Kroon, PhD
principal investigator · Quadram Institute Bioscience

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion